Staar Surgical (STAA) Capital Expenditures (2010 - 2026)

Staar Surgical has reported Capital Expenditures for 17 years, with the latest figure at $443000.0 in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures fell 69.82% year-over-year to $443000.0; the trailing twelve-month figure through Apr 2026 stood at $4.8 million (down 75.61% YoY), and the FY2026 full-year result was $5.8 million, down 75.12% from the prior year.
• Capital Expenditures for Q2 2026 stood at $443000.0, down from $1.7 million in the prior quarter.
• The five-year high for Capital Expenditures was $9.2 million in Q3 2023, with the low at $443000.0 in Q2 2026.
• Historically, Capital Expenditures has averaged $3.9 million across 5 years, with a median of $3.1 million in 2023.
• Annual changes were most pronounced in 2024 — Capital Expenditures jumped 106.9% — and 2025, when it slumped 85.83%.
• Staar Surgical's Capital Expenditures stood at $4.0 million in 2022, then decreased by 23.28% to $3.1 million in 2023, then jumped by 85.4% to $5.7 million in 2024, then tumbled by 84.58% to $883000.0 in 2025, then plunged by 49.83% to $443000.0 in 2026.
• The last three Capital Expenditures figures came in at $443000.0 (Q2 2026), $1.7 million (Q1 2026), and $883000.0 (Q3 2025), per Business Quant data.